US Pharma MarketingEli Lilly’s weekly insulin jab Onswik set for NHS use if approved
Eli Lilly’s weekly insulin jab Onswik set for NHS use if approved is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Lilly’s drug could cut the number of injections each patient needs by 85%.
Source: Pharmaceutical Technology